MILRINONE LACTATE

N/A

Manufactured by Baxter Healthcare Corporation

574 FDA adverse event reports analyzed

Last updated: 2026-04-15

About MILRINONE LACTATE

MILRINONE LACTATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Baxter Healthcare Corporation. The most commonly reported adverse reactions for MILRINONE LACTATE include DRUG INEFFECTIVE, HYPOTENSION, RENAL FAILURE, CARDIAC FAILURE, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MILRINONE LACTATE.

Top Adverse Reactions

DRUG INEFFECTIVE89 reports
HYPOTENSION15 reports
RENAL FAILURE13 reports
CARDIAC FAILURE12 reports
DYSPNOEA11 reports
CARDIAC ARREST10 reports
OFF LABEL USE10 reports
VENTRICULAR TACHYCARDIA10 reports
HAEMORRHAGE9 reports
MULTI ORGAN FAILURE9 reports
NAUSEA9 reports
RESPIRATORY FAILURE9 reports
CARDIAC FAILURE CONGESTIVE8 reports
CARDIOGENIC SHOCK8 reports
PAIN8 reports
RENAL FAILURE ACUTE8 reports
DEATH7 reports
INJURY7 reports
PYREXIA7 reports
SHOCK7 reports
TACHYCARDIA7 reports
CARDIAC DISORDER6 reports
CHEST PAIN6 reports
GENERAL PHYSICAL HEALTH DETERIORATION6 reports
LOSS OF CONSCIOUSNESS6 reports
PNEUMONIA6 reports
PRODUCT USE IN UNAPPROVED INDICATION6 reports
PULMONARY OEDEMA6 reports
RIGHT VENTRICULAR FAILURE6 reports
VOMITING6 reports
ACUTE KIDNEY INJURY5 reports
ANXIETY5 reports
AORTIC VALVE INCOMPETENCE5 reports
ATRIAL FIBRILLATION5 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION5 reports
EMOTIONAL DISTRESS5 reports
FALL5 reports
PULMONARY HYPERTENSION5 reports
SEPSIS5 reports
THERAPY NON RESPONDER5 reports
UNEVALUABLE EVENT5 reports
ABDOMINAL DISCOMFORT4 reports
ABDOMINAL PAIN4 reports
ANHEDONIA4 reports
CARDIO RESPIRATORY ARREST4 reports
COUGH4 reports
DEPRESSION4 reports
FEAR4 reports
HEPARIN INDUCED THROMBOCYTOPENIA4 reports
HYPOXIA4 reports
MALAISE4 reports
MYOCARDIAL INFARCTION4 reports
OEDEMA4 reports
OXYGEN SATURATION DECREASED4 reports
PLATELET AGGREGATION INHIBITION4 reports
PLEURAL EFFUSION4 reports
PULMONARY CONGESTION4 reports
REBOUND EFFECT4 reports
RENAL IMPAIRMENT4 reports
RENAL INJURY4 reports
SUPRAVENTRICULAR TACHYCARDIA4 reports
ASTHENIA3 reports
BLOOD PRESSURE DECREASED3 reports
BRADYCARDIA3 reports
BURKHOLDERIA TEST POSITIVE3 reports
CARDIAC DYSFUNCTION3 reports
CARDIAC FAILURE CHRONIC3 reports
DEVICE MALFUNCTION3 reports
DIALYSIS3 reports
DIZZINESS3 reports
FLUID OVERLOAD3 reports
GASTROINTESTINAL HAEMORRHAGE3 reports
HAEMOGLOBIN DECREASED3 reports
HEADACHE3 reports
HEPATIC FAILURE3 reports
HEPATIC FUNCTION ABNORMAL3 reports
HYPERTENSION3 reports
LUNG INFILTRATION3 reports
MEDICATION ERROR3 reports
MITRAL VALVE INCOMPETENCE3 reports
NEUTROPENIA3 reports
OEDEMA PERIPHERAL3 reports
OVERDOSE3 reports
PLATELET COUNT DECREASED3 reports
POST PROCEDURAL COMPLICATION3 reports
POST PROCEDURAL HAEMORRHAGE3 reports
PRODUCT USE ISSUE3 reports
RENAL FAILURE CHRONIC3 reports
RESPIRATORY DISTRESS3 reports
SEPTIC SHOCK3 reports
SYNCOPE3 reports
THROMBOCYTOPENIA3 reports
TOXIC EPIDERMAL NECROLYSIS3 reports
TRICUSPID VALVE INCOMPETENCE3 reports
WEIGHT INCREASED3 reports
ACIDOSIS2 reports
ANAEMIA2 reports
ANURIA2 reports
APNOEA2 reports
ARRHYTHMIA2 reports

Report Outcomes

Out of 270 classified reports for MILRINONE LACTATE:

Serious 93.0%Non-Serious 7.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male132 (57.1%)
Female99 (42.9%)

Reports by Age

Age 48 reports
Age 308 reports
Age 698 reports
Age 597 reports
Age 647 reports
Age 96 reports
Age 396 reports
Age 626 reports
Age 676 reports
Age 565 reports
Age 615 reports
Age 685 reports
Age 184 reports
Age 364 reports
Age 494 reports
Age 554 reports
Age 604 reports
Age 634 reports
Age 664 reports
Age 774 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MILRINONE LACTATE?

This profile reflects 574 FDA FAERS reports that mention MILRINONE LACTATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MILRINONE LACTATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, HYPOTENSION, RENAL FAILURE, CARDIAC FAILURE, DYSPNOEA, CARDIAC ARREST. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MILRINONE LACTATE?

Labeling and FAERS entries often list Baxter Healthcare Corporation in connection with MILRINONE LACTATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.